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Abstract 
Biofeedback is a conservative treatment based on behavioural techniques, which can be used in the 
management of bowel dysfunction. This article reports the results of a retrospective review of the 
clinical notes of 87 female patients attending a biofeedback service at St Mark’s Hospital, Harrow. 
The initial review was conducted to examine the incidence of polycystic ovary syndrome (PCOS) in 
patients attending this service. Seven percent were found to have PCOS, which is within the normal 
range. However, a significant proportion of patients (11.5%) had a current history of anorexia 
nervosa, a higher rate than in the general population, which prompted further investigation. In this 
article, Sonya Chelvanayagam, Julie Duncan, Brigitte Collins and Lorraine O’Brien report on the 
results of this review and discuss the significance of its findings 
Introduction 
Biofeedback is a conservative treatment based on behavioural techniques (Myung, 2010), which is 
used to alleviate a variety of conditions and symptoms including hypertension, anxiety and bowel 
conditions (Chiarioni and Whitehead, 2008). During biofeedback therapy, the patient is provided 
with visual or auditory information regarding their subconscious physiological processes, which they 
observe in real time. The biofeedback therapist instructs the patient on how to improve their 
physiological status, and by responding appropriately to these instructions, the patient is able to 
improve symptom control. 
Bowel dysfunction can be treated using biofeedback techniques, which may include the use of a 
transanal probe connected to a computer. The patient is placed in a suitable position to view the 
computer screen and observe the functioning of their anal sphincters as they respond to the 
therapist’s instructions. This provides immediate feedback, enables the patient to see and learn 
about their bowel function and provides an opportunity for the patient to learn suitable exercises to 
alleviate their symptoms (Norton et al, 2009). 
Assessment of bowel dysfunction and biofeedback therapy 
At St Mark’s Hospital, biofeedback therapy for bowel dysfunction is led by a nurse or 
physiotherapist, who is known as a ‘biofeedback therapist’. Following a comprehensive and 
individualised assessment, patients with faecal incontinence, chronic constipation or evacuation 
disorders are offered a course of treatment, which usually involves four appointments over a six-
month period. The therapist provides education of bowel function, diet and lifestyle, and a range of 
interventions are offered to help manage symptoms. These include sphincter exercises for patients 
with faecal incontinence, and bowel and muscle retraining for evacuation disorders, including 
constipation (Collins and Burch, 2009). For those with faecal incontinence, practical advice regarding 
the use of continence products, barrier creams and anal plugs is also provided (Norton and 
Chelvanayagam, 2004). Bowel irrigation may also be an option for some patients. 
The biofeedback therapist will also ask the patient whether they have been diagnosed with a mental 
disorder or experienced any mental health problems. Stress affects bowel function by increasing 
colonic activity and it can cause relapse of functional bowel disorders such as irritable bowel 
syndrome (IBS) and organic disorders, such as inflammatory bowel disease (IBD) (Bennett et al, 
1998; Mayer, 2000).  
Previous or current psychological distress or psychiatric illness can impact on bowel function (Mayer, 
2000; Emmanuel et al, 2001, Oudenhove et al, 2004; Jones et al, 2006) and can have a detrimental 
effect on, or cause, functional and organic bowel conditions (Brook, 1991; Drossman et al, 1995; 
Stern, 2003; Locke et al, 2004). The biofeedback therapist will also ask about traumatic childhood 
events. A literature review by Drossman et al (1995) found a high incidence (up to 56% in one 
centre) of sexual and physical abuse reported by patients attending gastrointestinal (GI) services in 
the USA and Europe. 
If the patient reports a history of psychological or psychiatric disorders, they will be asked if there is 
a correlation with the development of their bowel symptoms. Adverse life events (such as divorce or 
bereavement) may precipitate a functional gut disorder (Creed et al, 1988; Locke et al, 2004). 
Therefore, it is important to ask if there were any adverse life events prior to the onset of symptoms, 
or if symptoms have worsened with the occurrence of life events.If psychological issues are 
uncovered, the therapist discusses whether or not the patient would like to address them. St Mark’s 
Hospital has a specialist psychological medicine unit consisting of psychiatrists, psychologists and a 
counsellor, and provides assessment and treatment of both in- and outpatients with GI disorders 
and psychological problems.  
The consultant psychiatrist provides weekly supervision for all the specialist nurses and therapists 
working with people with GI disorders. At these sessions, they discuss the patients with 
psychological issues/mental disorders, how they can best support them during their treatment at St 
Mark’s Hospital and if they require referral to the psychological medicine unit (Stern, 2011).  
As bowel function remains a taboo topic, many patients are reluctant to reveal their symptoms. They 
may have experienced these symptoms for many years before disclosing them, which can have an 
impact on their psychosocial functioning (Norton and Chelvanayagam, 2004). Patients report that 
discussing bowel symptoms with an experienced health care practitioner is therapeutic. The 
opportunity to ask questions within a supportive environment has proved beneficial and plays a key 
role in the reduction of symptoms (Norton et al, 2003; Chiarioni and Whitehead, 2008). More than 
two thirds of patients who have biofeedback treatment for evacuation disorders or faecal 
incontinence have successful outcomes (Whitehead and Barucha, 2010). 
Audit of biofeedback service for polycystic ovary syndrome 
Therapists within the biofeedback clinic observed that a number of female patients of reproductive 
age who were being seen at the clinic had been diagnosed with or appeared to have symptoms of 
polycystic ovary syndrome (PCOS). The features of PCOS are listed in Table 1. These patients 
appeared to have less successful results with biofeedback therapy, and a literature review was 
undertaken to see if there was any relevant evidence identifying a correlation between PCOS and 
bowel dysfunction.  
PCOS is the most common endocrine disorder affecting women during childbearing years (Teede et 
al, 2010); it affects 4–18% of women of reproductive age (Moran et al, 2011) and 5–10% of all 
women (Homburg, 2008). Its cause is unknown, although there appears to be a genetic link 
(McCurtis, 2008). Essentially, the ovaries of affected women produce excessive amounts of 
androgens, which causes hyperandrogenism and chronic anovulation. The syndrome was defined by 
the Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2003). Any two of the 
three features presented in Table 1confirm the diagnosis (Homburg, 2008).  
Whilst the literature search revealed a number of articles relating to the syndrome’s prevalence, 
diagnosis, effects on lifestyle and fertility, none were found that were relevant to bowel function. 
However, a more recent search identified one paper that examines whether or not women with 
PCOS are more likely to have symptoms of IBS compared with control (Mather et al, 2010). This 
study was questionnaire-based and the authors reported that 41.7% of women diagnosed with PCOS 
had symptoms of IBS, compared with 10.3% of the control group.  
Following the literature review, the authors reviewed the clinical notes of patients currently 
attending for biofeedback therapy. Because a comprehensive assessment is undertaken at the initial 
visit, information about pre-existing medical conditions, mental health, height, weight, menstrual 
cycle and pregnancies could be collected.  
We examined 87 sets of clinical notes of female patients of reproductive age, who attended the 
biofeedback clinic over a one-month period. We discovered that 8% (7) had been diagnosed with 
PCOS, which is within its prevalence range. All these patients were receiving biofeedback therapy for 
chronic constipation. Thus, contrary to our hypothesis, our patient group did not have an increased 
incidence of PCOS. Surprisingly, when examining these patients’ notes it became evident that 11.5% 
(10) were currently experiencing symptoms of anorexia nervosa. This had either been recorded in 
the clinical notes or detailed by the referring clinician. Those identified were aged 19–30 years and 
their BMI scores ranged 16.5–19kg/m2. Eight were receiving biofeedback treatment for constipation 
and two for faecal incontinence. These patients had already been referred to the psychological 
medicine unit for assessment and treatment.  
Eating disorders and anorexia nervosa  
An eating disorder is defined as a severe disturbance of eating habits, preoccupation with food and 
associated weight control behaviour. There is a significant impairment in both physical and 
psychological functioning. Individuals are usually severely dissatisfied with their appearance and 
have low self-esteem (Institute of Psychiatry, 2012).  
Eating disorders are classified into 4 groups (Royal College of Psychiatrists [RCP], 2005): 
 Anorexia nervosa 
 Bulimia nervosa 
 Atypical eating disorders; eating disorders not otherwise specified (EDNOS)  
 Binge eating disorder.  
Within the general population, anorexia nervosa affects 0.5–1% of women, bulimia nervosa affects 
1–4% of women and EDNOS, including binge eating disorder, affects 2% of the population (Keaschuk 
and Newton, 2009). 
Anorexia nervosa is a psychological condition in which the person has overvalued ideas regarding 
weight and shape, and starves in order to lose weight. They continue a regime of severe dieting and 
exercise, even when they are very emaciated, as they have an altered body image and still believe 
they are overweight, despite their appearance. Table 2 lists the diagnostic criteria and features of 
anorexia nervosa (American Psychiatric Association, 2000). 
This disorder usually begins during adolescence—a period of physical and psychological transition 
which can be perceived as frightening and uncontrollable. Anorexia nervosa often develops after 
starting a diet (Fairburn and Harrison, 2003), possibly with a group of friends. However, while friends 
may stop dieting, the person with anorexia nervosa continues to diet, eating fewer and fewer 
calories and use a range of techniques to continue to lose weight, and to conceal their weight loss. 
They can present as very emaciated—as low in weight as 30kg. However, they may conceal their 
body shape with layers of clothes or baggy, oversized clothes, which can delay detection of weight 
loss (Jenkins, 2005). The person does not lose their appetite as the term ‘anorexia’ suggests but 
severely controls and restricts their food intake in relation to their overvalued ideas regarding body 
image and what thinness represents—possibly in an attempt to halt their physical development into 
adulthood. People with anorexia nervosa frequently have low self-esteem, perfectionist traits and a 
need to maintain stringent control in their lives. They may also be depressed (RCP, 2009). As the 
condition persists, the desire to continue to lose weight increases, as does the secrecy and shame 
associated with it. The person may become increasingly withdrawn and isolated (Institute of 
Psychiatry, 2012). 
Often the individual will view their low weight as an accomplishment, not an affliction, and have a 
limited motivation to change (Casasnovas et al, 2007). They may feel they have increasing control 
over their bodies, especially when they experience symptoms such as amenorrhoea. It is usually a 
parent or partner that takes the person (often reluctantly) to see a healthcare practitioner (Jackman, 
2009).  
Eating disorders in GI services 
By nature, eating disorders have direct effects on the GI system. They involve abnormal eating 
patterns, calorie intake, purging of food, self-induced vomiting and abuse of laxatives (Winstead and 
Willard, 2006), so it is not surprising that some individuals with an eating disorder will attend, or be 
referred to, GI services. People with eating disorders may seek treatment for GI symptoms such as 
constipation, rather than accessing services to address their psychological needs (Andersen, 2004; 
Emmanuel et al, 2004; Winstead and Willard, 2006). Winstead and Willard (2006) interviewed 13 
inpatients at an eating disorder unit and discovered that eight had previously seen a 
gastroenterologist or general practitioner for GI symptoms, and six of these had sought treatment 
for these symptoms before seeking treatment for their eating disorder.  
Functional GI disorders such as irritable bowel syndrome and functional constipation are common in 
people with eating disorders (Porcelli et al, 1998; Boyd et al, 2005) and persist after the person is 
fully recovered from their eating disorder (Porcelli et al, 1998). Some people with eating disorders 
may prefer to address the physical symptoms, rather than accessing mental health services, due to 
the stigma and negative attitudes towards eating disorders (Crisp et al, 2000; Mond et al, 2006). 
Recommendations and implications for practice 
Members of the biofeedback team were not surprised to find a high prevalence of anorexia nervosa 
within the clinic, as they had previously considered that significant numbers of patients with, not just 
anorexia nervosa, but other eating disorders, were being managed by the service. The review of 
clinical notes confirmed that this was a significant issue, and management of this patient group 
requires appropriate knowledge, skills and supervision (Swatton, 2011).  
Delaying access to appropriate treatment for people with eating disorders can be fatal. Anorexia 
nervosa, if untreated, has the highest mortality rate of all mental disorders—up to 20% die 
prematurely from medical complications or suicide (Beat, 2010). However, the patients highlighted 
in this paper had already been referred to our psychological medicine unit. Of greater concern is 
patients who are not receiving treatment for their eating disorder, and only addressing GI 
symptoms. Due to a lack of recognition and secrecy surrounding eating disorders, these people may 
not disclose details of their eating behaviours and may undergo a range of inappropriate 
examinations and investigations. Delays accessing necessary assessment and treatment may lead to 
a detrimental effect on health.  
Our finding highlighted the need for further investigation, and a cross-sectional survey has just been 
completed to examine the incidence of eating disorders in patients with functional and organic GI 
disorders at St Mark’s Hospital. It is hoped that recognition of the increased risk of people with 
eating disorders attending GI services will lead to greater awareness and ensure that patients 
receive appropriate assessment and treatment as soon as possible. 
Conclusion 
This paper highlights three issues. Firstly, that to examine the evidence to answer one question can 
sometimes uncover other questions and concerns which need to be addressed. In this instance, 
investigating the incidence of PCOS in patients attending the biofeedback clinic at St Mark’s Hospital 
led to the discovery of an increased incidence of anorexia nervosa. Secondly, this discovery meant 
that further investigation was required regarding the incidence of eating disorders within GI services 
at St Mark’s Hospital. A literature review supported this finding and a cross-sectional study was 
performed to examine the incidence of eating disorders within GI services. The results of this study 
will be reported in due course. Thirdly, this paper highlights that patients attending GI services are 
more likely to have experienced psychological distress and/or mental illness, which may be 
precipitated or perpetuated by their GI disorder. The stigma surrounding bowel dysfunction can 
cause additional suffering. The assessment of patients attending GI services needs to address 
physical, psychological and social functioning. To ensure that the patient feels able to voice their 
concerns and therefore receive appropriate and effective care, the development of a therapeutic 
relationship is crucial. 
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Table 1. Features of polycystic ovary syndrome 
(PCOS) 
 
Oligo- or anovulation infertility Decreased, irregular or no menstrual cycle, 
causing  
Hyperandrogenism 
 
Symptoms include excessive hair growth on face,  
breasts, back, abdomen and legs, and acne 
Polycystic ovaries on ultrasound examination  
 
Table 2. Diagnostic criteria and features of anorexia nervosa 
Refusal to maintain normal body weight; the body mass index (BMI) may be 17.5kg/m2 or less, 15% 
or more lower than expected 
Fear of weight gain or becoming fat (although underweight) 
Body image distortion; there is fear of fatness, overvalued ideas regarding weight and shape and an 
imposed low weight threshold 
Amenorrhoea, for at least three consecutive menstrual cycles. Men may report loss of libido and loss 
of early morning erections 
Two subtypes of anorexia nervosa:  
 Restricting subtype—food restriction and starvation 
 Binge/purge subtype—food restriction, excessive exercise and purging behaviours (such as 
use of laxatives and self-induced vomiting); may use appetite suppressants 
 
